This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Stephen Sander, PharmD
Advertisement
Articles by Stephen Sander, PharmD
Advertisement
Latest Updated Articles
- Resource Use Among Nonvalvular Atrial Fibrillation Patients
Published: October 19th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
3
Medetomidine: The Demon in the Illicit Fentanyl Supply
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5
